Basel Medical Group Statistics
Total Valuation
BMGL has a market cap or net worth of $84.38 million. The enterprise value is $79.83 million.
Market Cap | 84.38M |
Enterprise Value | 79.83M |
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
BMGL has 18.75 million shares outstanding.
Current Share Class | n/a |
Shares Outstanding | 18.75M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | n/a |
Valuation Ratios
The trailing PE ratio is 25.52.
PE Ratio | 25.52 |
Forward PE | n/a |
PS Ratio | 6.56 |
Forward PS | n/a |
PB Ratio | 16.82 |
P/TBV Ratio | n/a |
P/FCF Ratio | 68.86 |
P/OCF Ratio | 68.48 |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | 24.14 |
EV / Sales | 6.20 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | 65.15 |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | 1.01 |
Debt / EBITDA | n/a |
Debt / FCF | 4.13 |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 36.77% and return on invested capital (ROIC) is 25.34%.
Return on Equity (ROE) | 36.77% |
Return on Assets (ROA) | n/a |
Return on Capital (ROIC) | 25.34% |
Revenue Per Employee | $415,040 |
Profits Per Employee | $106,658 |
Employee Count | 31 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (5Y) | n/a |
52-Week Price Change | n/a |
50-Day Moving Average | n/a |
200-Day Moving Average | n/a |
Relative Strength Index (RSI) | n/a |
Average Volume (20 Days) | n/a |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BMGL had revenue of $12.87 million and earned $3.31 million in profits. Earnings per share was $0.18.
Revenue | 12.87M |
Gross Profit | 5.50M |
Operating Income | 2.56M |
Pretax Income | 1.84M |
Net Income | 3.31M |
EBITDA | n/a |
EBIT | n/a |
Earnings Per Share (EPS) | $0.18 |
Full Income Statement Balance Sheet
The company has $9.61 million in cash and $5.07 million in debt, giving a net cash position of $4.55 million or $0.24 per share.
Cash & Cash Equivalents | 9.61M |
Total Debt | 5.07M |
Net Cash | 4.55M |
Net Cash Per Share | $0.24 |
Equity (Book Value) | 5.02M |
Book Value Per Share | 0.27 |
Working Capital | n/a |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was $1.23 million and capital expenditures -$6,933, giving a free cash flow of $1.23 million.
Operating Cash Flow | 1.23M |
Capital Expenditures | -6,933 |
Free Cash Flow | 1.23M |
FCF Per Share | $0.07 |
Full Cash Flow Statement Margins
Gross margin is 42.71%, with operating and profit margins of 19.86% and 25.70%.
Gross Margin | 42.71% |
Operating Margin | 19.86% |
Pretax Margin | 14.34% |
Profit Margin | 25.70% |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | 9.52% |